Genmab A (GMAB) Revenue (2018 - 2026)
Genmab A's (GMAB) quarterly Revenue came in at $896.0 million in Q1 2026, up 25.31% YoY from $715.0 million in Q1 2025, and down 66.34% on a QoQ basis from $2.7 billion in Q3 2025.
Genmab A (GMAB) Revenue (2018 - 2026) Analysis & Trends
Genmab A (GMAB) has 6 years of Revenue data on file, last reported at $896.0 million in Q1 2026.
- Quarterly Revenue rose 25.31% year-over-year to $896.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 billion (up 20.72% YoY) and the FY2025 annual result came in at $3.7 billion, up 19.19% from the prior year.
- Revenue eased to $896.0 million in Q1 2026, from $2.7 billion in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.7 billion in Q3 2025 to a low of $603.0 million in Q1 2024.
- A 3-year average of $1.4 billion and a median of $1.4 billion in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2025 — Revenue rose 18.57% — and 2026, when it climbed 25.31%.
- Tracing GMAB's Revenue over 3 years: stood at $2.2 billion in 2024, then advanced by 21.11% to $2.7 billion in 2025, then slumped by 66.34% to $896.0 million in 2026.
- The last three Revenue figures came in at $896.0 million (Q1 2026), $2.7 billion (Q3 2025), and $1.6 billion (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 896.00 Mn |
| Sep 30, 2025 | 2.66 Bn |
| Jun 30, 2025 | 1.64 Bn |
| Mar 31, 2025 | 715.00 Mn |
| Sep 30, 2024 | 2.20 Bn |
| Jun 30, 2024 | 1.38 Bn |
| Mar 31, 2024 | 603.00 Mn |
| Sep 30, 2020 | 1,724,000.00 Bn |
| Dec 31, 2019 | 1.04 Bn |
| Sep 30, 2019 | 0.00 |
| Dec 31, 2018 | 598.60 Mn |